Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.
Open Access
- 3 April 1993
- Vol. 306 (6882) , 890-894
- https://doi.org/10.1136/bmj.306.6882.890
Abstract
OBJECTIVE--To determine whether prolonged infection with hepatitis B virus is associated with a lower blood cholesterol concentration. DESIGN--Cross sectional study. SETTING--81 villages in rural China with a high prevalence of chronic infection with hepatitis B virus. SUBJECTS--1556 apparently healthy men aged 35-64 years, randomly selected. MAIN OUTCOME MEASURES--Hepatitis B virus carrier state; plasma concentrations of cholesterol, apolipoprotein B, and apolipoprotein A I. RESULTS--238 (15%) of the men were positive for hepatitis B surface antigen, indicating that they were chronic carriers. Plasma concentration of cholesterol was 4.2% (0.11 mmol/l) lower among carriers (that is, positive for hepatitis B surface antigen) than among non-carriers (95% confidence interval 0.6% to 8.0% (0.01 to 0.21 mmol/l), p < 0.05), and apolipoprotein B concentration was 7.0% (0.036 g/l) lower (2.8% to 11.2% (0.014 to 0.058 g/l), p < 0.001). In contrast, no association was observed between plasma concentrations of cholesterol or apolipoprotein and hepatitis B that had been eradicated (that is, patient positive for hepatitis B core antibody but negative for hepatitis B surface antigen). CONCLUSIONS--Chronic hepatitis B virus infection, which usually starts in early childhood in China, seems to lead not only to a greatly increased risk of death from liver disease but also to a somewhat lower cholesterol concentration in adulthood. This common cause produces an inverse association between cholesterol concentration and risk of death from liver cancer or from other chronic liver diseases.Keywords
This publication has 30 references indexed in Scilit:
- Determination of serum cholesterol concentration in the presence of ascorbate.Journal of Clinical Pathology, 1993
- Lipoprotein(a) in cirrhosis.BMJ, 1992
- Hypocholesterolaemic factor from gallbladder cancer cellsThe Lancet, 1990
- Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.BMJ, 1989
- Serum cholesterol and risk of cancer in a cohort of 39,000 men and womenJournal of Clinical Epidemiology, 1988
- SERUM CHOLESTEROL AND CANCER IN THE NHANES I EPIDEMIOLOGICAL FOLLOW-UP STUDYThe Lancet, 1987
- Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studiesJournal of Chronic Diseases, 1981
- PLASMA LIPIDS AND MORTALITY: A SOURCE OF ERRORThe Lancet, 1980
- Cholesterol and mortality in New Zealand Maoris.BMJ, 1980
- Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin GImmunochemistry, 1971